Interestingly, mutations in AHNAK and AHNAK2, both of which are involved in RNA splicing, represented clusters with dissimilar prognoses, implying their different roles in ESCC progression. The gene discussed is AHNAK; the disease is esophageal squamous cell carcinoma.